Electromedical Technologies, Inc (EMED) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
16561 N 92ND STREET SCOTTSDALE, AZ 85260 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 88 | 368 | 383 | 265 | |||
| Cash and cash equivalent | 88 | 368 | 383 | 265 | |||
| Receivables | 4 | 9 | 35 | 18 | |||
| Inventory, net of allowances, customer advances and progress billings | 69 | 62 | 219 | 79 | |||
| Inventory | 69 | 62 | 219 | 79 | |||
| Deferred costs | 20 | ||||||
| Other undisclosed current assets | 289 | 208 | 38 | 266 | |||
| Total current assets: | 449 | 648 | 675 | 647 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 149 | ||||||
| Property, plant and equipment | 150 | 705 | 727 | 749 | |||
| Other noncurrent assets | 21 | ||||||
| Total noncurrent assets: | 299 | 705 | 727 | 770 | |||
| TOTAL ASSETS: | 748 | 1,353 | 1,402 | 1,417 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 278 | 461 | 133 | 115 | |||
| Accounts payable | 239 | 267 | 215 | 263 | |||
| Accrued liabilities | 38 | 194 | |||||
| Other undisclosed accounts payable and accrued liabilities | (82) | (147) | |||||
| Deferred revenue | 197 | 218 | 29 | ||||
| Debt | 49 | 32 | 30 | 41 | |||
| Deferred compensation liability | 21 | ||||||
| Derivative instruments and hedges, liabilities | 532 | 832 | |||||
| Other undisclosed current liabilities | 2,300 | 2,193 | 1,280 | 1,002 | |||
| Total current liabilities: | 3,357 | 2,924 | 1,442 | 2,019 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 256 | 640 | 673 | 701 | |||
| Long-term debt, excluding current maturities | 150 | 640 | 673 | 701 | |||
| Finance lease, liability | 106 | ||||||
| Liabilities, other than long-term debt | 8 | 10 | 9 | 16 | |||
| Other liabilities | 8 | 10 | 9 | 16 | |||
| Operating lease, liability | |||||||
| Total noncurrent liabilities: | 265 | 650 | 682 | 716 | |||
| Total liabilities: | 3,621 | 3,574 | 2,125 | 2,736 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | (2,873) | (2,221) | (723) | (1,319) | |||
| Preferred stock | 355 | ||||||
| Common stock | 5 | 2 | 1 | 0 | |||
| Additional paid in capital | 23,827 | 22,237 | 20,804 | 7,958 | |||
| Accumulated deficit | (27,470) | (24,825) | (21,883) | (9,632) | |||
| Other undisclosed equity, attributable to parent | 765 | 365 | 355 | ||||
| Total equity: | (2,873) | (2,221) | (723) | (1,319) | |||
| TOTAL LIABILITIES AND EQUITY: | 748 | 1,353 | 1,402 | 1,417 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues | 1,349 | 1,150 | 907 | 738 | ||
| Cost of revenue | (303) | (261) | (199) | (194) | ||
| Gross profit: | 1,046 | 889 | 708 | 544 | ||
| Operating expenses | (3,110) | (2,492) | (4,508) | (3,710) | ||
| Operating loss: | (2,065) | (1,604) | (3,800) | (3,167) | ||
| Nonoperating expense | (576) | (1,865) | (4,680) | (705) | ||
| Other nonoperating expense | (576) | (1,865) | (4,680) | (705) | ||
| Interest and debt expense | 8 | (1,080) | (3,314) | (770) | ||
| Loss from continuing operations: | (2,633) | (4,548) | (11,794) | (4,641) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (11,794) | (4,641) | |
| Other undisclosed net income (loss) | (8) | 1,080 | 3,314 | |||
| Net loss: | (2,641) | (3,469) | (8,480) | (4,641) | ||
| Other undisclosed net income attributable to parent | 770 | |||||
| Net loss attributable to parent: | (2,641) | (3,469) | (8,480) | (3,872) | ||
| Other undisclosed net loss available to common stockholders, basic | (3) | (108) | (3,771) | |||
| Net loss available to common stockholders, diluted: | (2,645) | (3,576) | (12,251) | (3,872) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net loss: | (2,641) | (3,469) | (8,480) | (4,641) | ||
| Comprehensive loss, net of tax, attributable to parent: | (2,641) | (3,469) | (8,480) | (4,641) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.